Skip to main content

Ortivus AB (publ) quarterly report for the period January – March 2021

2021-04-27 08:30

Ortivus is growing and attracting additional distributors. Operating cash flow improved to 5.1 MSEK during the first quarter 2021.

Highlights Jan – Mar 2021

  • Ortivus has signed a distribution agreement with Bexen Cardio Italia Srl to create new marketing and sales channels in Italy.

Jan – Mar 2021

  • Net sales amounted to 23.5 (20.2) MSEK, which is an increase in sales of 17%
  • Operating cash flow amounted to 5.1 (3.2) MSEK
  • Operating profit amounted to 1.7 (1.1) MSEK
  • Profit after tax was 1.7 (1.1) MSEK
  • Earnings per share after tax and before and after dilution amounted to 0.04 (0.02) SEK
Amount in KSEK Jan-Mar 2021 Jan-Mar 2020 Jan-Dec 2020
Net sales 23 542 20 161 107 582
Gross margin, % 50.1% 44.4% 36.2%
Operating cash flow 5 104 3 166 11 895
Operating profit 1 733 1 112 11 392
Operating margin, % 7.4% 5.5% 10.5%

Get in touch

Empower your team with smarter tools

Discover why leading healthcare organisations are choosing Ortivus.

Get contacted

Fill in the form and one of our sales representatives will contact you as soon as possible.

Required